Yoriko Takezako
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 5
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Cancer Genomics and Diagnostics 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Cancer therapeutics and mechanisms 3
-
- Neuroendocrine Tumor Research Advances 2
Yoriko Takezako
13 papers receiving 394 citations
Peers
Comparison fields: 5 of 44
- Oncology 293
- Hepatology 74
- Pulmonary and Respiratory Medicine 188
- Cancer Research 77
- Surgery 182
Countries citing papers authored by Yoriko Takezako
This map shows the geographic impact of Yoriko Takezako's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoriko Takezako with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoriko Takezako more than expected).
Fields of papers citing papers by Yoriko Takezako
This network shows the impact of papers produced by Yoriko Takezako. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoriko Takezako. The network helps show where Yoriko Takezako may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Yoriko Takezako, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 7 | |
| 2 | Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC). | 2009 | 2 |
| 3 | 2005 | 93 | |
| 4 | 2005 | 66 | |
| 5 | 2005 | 13 | |
| 6 | 2004 | 124 | |
| 7 | 2004 | 87 | |
| 8 | 2004 | 7 | |
| 9 | 2004 | 1 | |
| 10 | 2004 | 1 | |
| 11 | [Tumor markers for pancreatic and biliary tract cancer]. | 2004 | 5 |
| 12 | 2003 | 1 | |
| 13 | 1999 | 1 |
About Yoriko Takezako
Yoriko Takezako is a scholar working on Hepatology, Oncology, Molecular Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 13 papers that have together received 408 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer therapeutics and mechanisms (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (293 citations), Hepatology (74 citations), Pulmonary and Respiratory Medicine (188 citations), Cancer Research (77 citations) and Surgery (182 citations). Yoriko Takezako has collaborated with scholars based in Japan and United States. Frequent co-authors include Chigusa Morizane, Takuji Okusaka, Masafumi Ikeda, Hideki Ueno, Yoshikazu Kagami, Hiroshi Ikeda, Yoshinori Ito, Hideki Ueno, Hiroshi Semba and Takashi Seto. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Oncology, Cancer and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.